US Stock MarketDetailed Quotes

XBiotech (XBIT)

Watchlist

2.460
-0.040-1.60%

Close May 15 16:00 ET

2.440
-0.020-0.81%

Post 20:01 ET

75.00MMarket Cap-1.88P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

XBiotech (XBIT) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

31.11%55.69M

240.13%29.76M

-23.49%6.05M

-57.66%6.34M

24.85%13.55M

13.23%42.47M

1.87%8.75M

-7.23%7.9M

12.88%14.97M

51.90%10.85M

Selling and administrative expenses

75.97%8.3M

374.33%4.4M

24.45%967K

-49.55%1M

87.84%1.93M

1.12%4.71M

18.39%927K

-20.14%777K

-0.50%1.98M

12.35%1.03M

-General and administrative expense

75.97%8.3M

374.33%4.4M

24.45%967K

-49.55%1M

87.84%1.93M

1.12%4.71M

18.39%927K

-20.14%777K

-0.50%1.98M

12.35%1.03M

Research and development costs

25.51%47.39M

224.23%25.36M

-28.72%5.08M

-58.90%5.34M

18.26%11.62M

14.94%37.76M

0.22%7.82M

-5.57%7.13M

15.25%12.98M

57.70%9.83M

Operating profit

-31.11%-55.69M

-240.13%-29.76M

23.49%-6.05M

57.66%-6.34M

-24.85%-13.55M

-13.23%-42.47M

-1.87%-8.75M

7.23%-7.9M

-12.88%-14.97M

-51.90%-10.85M

Net non-operating interest income expense

-37.91%5.59M

-35.57%1.22M

-34.12%1.43M

-38.53%1.53M

-42.39%1.42M

-13.59%9.01M

-27.31%1.89M

-14.35%2.17M

-0.80%2.49M

-11.55%2.46M

Non-operating interest income

-42.12%5.68M

-41.84%1.22M

-39.76%1.43M

-43.10%1.53M

-43.42%1.5M

-5.84%9.81M

-19.48%2.1M

-6.33%2.37M

7.17%2.69M

-4.35%2.66M

Non-operating interest expense

-89.10%88K

--0

-56.00%88K

--807K

--204K

--203K

--200K

Other net income (expense)

193.96%4.79M

146.57%1.72M

-275.68%-1.29M

655.60%3.08M

180.85%1.28M

-283.61%-5.1M

-395.44%-3.69M

168.73%732K

-126.66%-554K

-408.38%-1.58M

Gain on sale of security

160.28%3.33M

128.54%1.17M

-269.87%-1.2M

656.14%3.08M

117.95%284K

-392.08%-5.53M

-428.79%-4.1M

166.38%707K

-141.72%-554K

-513.05%-1.58M

Other non- operating income (expenses)

237.04%1.46M

35.14%550K

-440.00%-85K

98.50%-3K

597.50%995K

-51.08%432K

13,466.67%407K

--25K

-126.67%-200K

-253.85%-200K

Income before tax

-17.48%-45.31M

-154.20%-26.82M

-17.98%-5.91M

86.74%-1.73M

-8.80%-10.86M

-58.61%-38.56M

-122.83%-10.55M

29.05%-5.01M

-50.28%-13.03M

-158.94%-9.98M

Income tax

834.38%235K

285.37%76K

1,033.33%102K

212.00%28K

16.00%29K

-113.11%-32K

58.59%-41K

-97.08%9K

-135.21%-25K

167.57%25K

Net income

-18.19%-45.54M

-155.92%-26.89M

-19.80%-6.01M

86.50%-1.76M

-8.82%-10.88M

-56.90%-38.53M

-126.71%-10.51M

31.90%-5.02M

-48.78%-13.01M

-162.11%-10M

Net income continuous Operations

-18.19%-45.54M

-155.92%-26.89M

-19.80%-6.01M

86.50%-1.76M

-8.82%-10.88M

-56.90%-38.53M

-126.71%-10.51M

31.90%-5.02M

-48.78%-13.01M

-162.11%-10M

Minority interest income

Net income attributable to the parent company

-18.19%-45.54M

-155.92%-26.89M

-19.80%-6.01M

86.50%-1.76M

-8.82%-10.88M

-56.90%-38.53M

-126.71%-10.51M

31.90%-5.02M

-48.78%-13.01M

-162.11%-10M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-18.19%-45.54M

-155.92%-26.89M

-19.80%-6.01M

86.50%-1.76M

-8.82%-10.88M

-56.90%-38.53M

-126.71%-10.51M

31.90%-5.02M

-48.78%-13.01M

-162.11%-10M

Basic earnings per share

-18.25%-1.49

-158.82%-0.88

-25.00%-0.2

86.05%-0.06

-9.09%-0.36

-55.56%-1.26

-112.50%-0.34

33.33%-0.16

-48.28%-0.43

-153.85%-0.33

Diluted earnings per share

-18.25%-1.49

-158.82%-0.88

-25.00%-0.2

86.05%-0.06

-9.09%-0.36

-55.56%-1.26

-112.50%-0.34

33.33%-0.16

-48.28%-0.43

-153.85%-0.33

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	31.11%55.69M	240.13%29.76M	-23.49%6.05M	-57.66%6.34M	24.85%13.55M	13.23%42.47M	1.87%8.75M	-7.23%7.9M	12.88%14.97M	51.90%10.85M
Selling and administrative expenses	75.97%8.3M	374.33%4.4M	24.45%967K	-49.55%1M	87.84%1.93M	1.12%4.71M	18.39%927K	-20.14%777K	-0.50%1.98M	12.35%1.03M
-General and administrative expense	75.97%8.3M	374.33%4.4M	24.45%967K	-49.55%1M	87.84%1.93M	1.12%4.71M	18.39%927K	-20.14%777K	-0.50%1.98M	12.35%1.03M
Research and development costs	25.51%47.39M	224.23%25.36M	-28.72%5.08M	-58.90%5.34M	18.26%11.62M	14.94%37.76M	0.22%7.82M	-5.57%7.13M	15.25%12.98M	57.70%9.83M
Operating profit	-31.11%-55.69M	-240.13%-29.76M	23.49%-6.05M	57.66%-6.34M	-24.85%-13.55M	-13.23%-42.47M	-1.87%-8.75M	7.23%-7.9M	-12.88%-14.97M	-51.90%-10.85M
Net non-operating interest income expense	-37.91%5.59M	-35.57%1.22M	-34.12%1.43M	-38.53%1.53M	-42.39%1.42M	-13.59%9.01M	-27.31%1.89M	-14.35%2.17M	-0.80%2.49M	-11.55%2.46M
Non-operating interest income	-42.12%5.68M	-41.84%1.22M	-39.76%1.43M	-43.10%1.53M	-43.42%1.5M	-5.84%9.81M	-19.48%2.1M	-6.33%2.37M	7.17%2.69M	-4.35%2.66M
Non-operating interest expense	-89.10%88K	--0	--0	--0	-56.00%88K	--807K	--204K	--203K	--200K	--200K
Other net income (expense)	193.96%4.79M	146.57%1.72M	-275.68%-1.29M	655.60%3.08M	180.85%1.28M	-283.61%-5.1M	-395.44%-3.69M	168.73%732K	-126.66%-554K	-408.38%-1.58M
Gain on sale of security	160.28%3.33M	128.54%1.17M	-269.87%-1.2M	656.14%3.08M	117.95%284K	-392.08%-5.53M	-428.79%-4.1M	166.38%707K	-141.72%-554K	-513.05%-1.58M
Other non- operating income (expenses)	237.04%1.46M	35.14%550K	-440.00%-85K	98.50%-3K	597.50%995K	-51.08%432K	13,466.67%407K	--25K	-126.67%-200K	-253.85%-200K
Income before tax	-17.48%-45.31M	-154.20%-26.82M	-17.98%-5.91M	86.74%-1.73M	-8.80%-10.86M	-58.61%-38.56M	-122.83%-10.55M	29.05%-5.01M	-50.28%-13.03M	-158.94%-9.98M
Income tax	834.38%235K	285.37%76K	1,033.33%102K	212.00%28K	16.00%29K	-113.11%-32K	58.59%-41K	-97.08%9K	-135.21%-25K	167.57%25K
Net income	-18.19%-45.54M	-155.92%-26.89M	-19.80%-6.01M	86.50%-1.76M	-8.82%-10.88M	-56.90%-38.53M	-126.71%-10.51M	31.90%-5.02M	-48.78%-13.01M	-162.11%-10M
Net income continuous Operations	-18.19%-45.54M	-155.92%-26.89M	-19.80%-6.01M	86.50%-1.76M	-8.82%-10.88M	-56.90%-38.53M	-126.71%-10.51M	31.90%-5.02M	-48.78%-13.01M	-162.11%-10M
Minority interest income
Net income attributable to the parent company	-18.19%-45.54M	-155.92%-26.89M	-19.80%-6.01M	86.50%-1.76M	-8.82%-10.88M	-56.90%-38.53M	-126.71%-10.51M	31.90%-5.02M	-48.78%-13.01M	-162.11%-10M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-18.19%-45.54M	-155.92%-26.89M	-19.80%-6.01M	86.50%-1.76M	-8.82%-10.88M	-56.90%-38.53M	-126.71%-10.51M	31.90%-5.02M	-48.78%-13.01M	-162.11%-10M
Basic earnings per share	-18.25%-1.49	-158.82%-0.88	-25.00%-0.2	86.05%-0.06	-9.09%-0.36	-55.56%-1.26	-112.50%-0.34	33.33%-0.16	-48.28%-0.43	-153.85%-0.33
Diluted earnings per share	-18.25%-1.49	-158.82%-0.88	-25.00%-0.2	86.05%-0.06	-9.09%-0.36	-55.56%-1.26	-112.50%-0.34	33.33%-0.16	-48.28%-0.43	-153.85%-0.33
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm